Guardion Health Sciences Stock News

Guardion Health Sciences (GHSI) has plunged 43% pre-market after pricing its previously announced public offering of shares and warrants, with anticipated gross proceeds of…

HOUSTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutriti

Guardion Health Sciences (GHSI) trades 19.6% down premarket after it announced plans to offer and sell shares and warrants in a public offering.Offer size, terms have not yet…

New Omega BOOST™ Gel Bites Provide 10x More Omega-3 Than Leading Gummies Individually Packaged in Blisterpacks to Ensure Freshness and Portability Omega BOOST™ is the First New Viactiv ® Product Launch Since Guardion Acquired the Brand in June 2021 HOUSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. ("Guardion" or the "Company") (NASDAQ: GHSI ), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announced the launch of Viactiv Omega BOOST gel bites, the Company''s first expansion of the Viactiv brand since the Company acquired it in June 2021. The 1,200 mg Omega-3 gel bites are designed to provide total body support, including cardiovascular, brain, joint and eye health. The new dosage form is able to provide the potency of large, hard-to-swallow soft gels, in a great tasting chewable format that has ten times more Omega-3 than the leading fish oil gummies. The gel bite dosage form has been shown to have better absorption and fewer digestive issues than regular soft gel formulas, as well as no unpleasant fishy aftertaste and no sugar, which can all be associated with certain other Omega-3 products. "Our new Omega Boost product is an exciting addition to our Viactiv line as it introduces a new dosage form that addresses a gap in the Omega-3 market – clinically …

Guardion Health Sciences (GHSI) a clinical nutrition company, has announced the launch of its new branded Shopify store for its Viactiv line of products

New e-commerce venue to offer all Viactiv products and additional educational content to enhance user experience New e-commerce venue to offer all Viactiv products and additional educational content t

Guardion Health Sciences Inc (GHSI) shares closed today at 0.1% above its 52 week low of $0.62, giving the company a market cap of $15M. The stock is currently down 3.9% year-to-date, down 85.2% over the past 12 months, and down 97.2% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 53.9% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Alibaba Group Holding Limited (NYSE:BABA) with the stream of 0.72% also noticed, India Guardion Health Sciences, Inc. (NASDAQ:GHSI) encountered a rapid change of -1.66% in the last hour of Thursdays The post Eye-catching Stock Analysis: Alibaba Group Holding Limited (NYSE:BABA), Guardion Health Sciences, Inc. (NASDAQ:GHSI) appeared first on Stocks Equity .

Management Anticipates $300,000+ Reduction in Annual Operating Costs Management Anticipates $300,000+ Reduction in Annual Operating Costs

Management Anticipates $300,000+ Reduction in Annual Operating Costs Management Anticipates $300,000+ Reduction in Annual Operating Costs

HOUSTON, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (Guardion or the Company), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements, and medical devices, announced today that Michaela Griggs, a seasoned healthcare executive, has been appointed to its Board of Directors.

New Gold Inc. (NGD) with the stream of -2.17% also noticed, India Guardion Health Sciences, Inc. (GHSI) encountered a rapid change of -8.34% in the last hour of Fridays trading The post Remarkable Stock in Focus: New Gold Inc. (AMEX:NGD), Guardion Health Sciences, Inc. (NASDAQ:GHSI) appeared first on Stocks Equity .

HOUSTON, Dec. 03, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically

Vanguard Group Inc. raised its stake in Guardion Health Sciences, Inc. (NASDAQ:GHSI) by 83.2% in the second quarter, HoldingsChannel reports. The institutional investor owned 1,069,815 shares of the companys stock after buying an additional 485,870 shares during the quarter. Vanguard Group Inc.s holdings in Guardion Health Sciences were worth $1,883,000 at the end of the []

Guardion Health Sciences Inc. (NASDAQ:GHSI) shares, rose in value on Wednesday, 11/24/21, with the stock price up by 1.85% to the previous days close as strong demand from buyers drove the stock to $1.10. Actively observing the price movement in the last trading, the stock closed the session at $1.08, falling within a range of Selling Your Guardion Health Sciences Inc. (NASDAQ: GHSI) Stock? Heres What You Need To Know Read More »